Telix Completes Acquisition of Next-Generation Therapeutic Assets
Telix Pharmaceuticals Limited, announces it has completed the acquisition from antibody engineering company ImaginAb, (ImaginAb). The acquisition includes a pipeline of next-generation therapeutic candidates, a proprietary novel biologics technology...